欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/2328/001
药品名称Cytarabine 100mg/ml Solution for Infusion or Injection
活性成分
    • Cytarabine 100.0 µg
剂型solution for injection or infusion
上市许可持有人FRESENIUS KABI ONCOLOGY PLC LION COURT FARNHAM ROAD BORDON HAMPSHIRE GU35 0NF UNITED KINGDOM
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 18727/0024 - 0013
    • Denmark (DK)
      Cytarabin "Fresenius Kabi"
    • Belgium (BE)
    • Netherlands (NL)
      Cytarabine Fresenius Kabi 100 mg/ml Oplossing voor injectie of infusie
    • Iceland (IS)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Cytarabin Fresenius Kabi
    • Poland (PL)
      Cytarabine Kabi
    • Latvia (LV)
    • Lithuania (LT)
      Cytarabine Kabi 100 mg/ml injekcinis/infuzinis tirpalas
    • Estonia (EE)
      CYTARABINE KABI
    • Hungary (HU)
      CYTARABINE KABI 100 mg/ml oldatos injekció vagy infúzió
    • Romania (RO)
      Citarabina Kabi 100 mg/ml soluţie injectabilă sau perfuzabilă
    • Ireland (IE)
许可日期2012/05/10
最近更新日期2025/09/22
药物ATC编码
    • L01BC01 cytarabine
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase